(Date:9/5/2008)...On Saturday, September 6, PARI,Respiratory Equipme...ay,s,Family as part of their "Breathe Easier" seri...e company that provides patients, such as COPD,suf...that deliver needed,medications directly to the lu...e affected by respiratory,diseases and those who c...
(Date:9/5/2008)...disease resistance to anti-hormonal therapy , ...ug sorafenib may help "re-sensitize" certain breas...n University Medical Center researchers say. , ...tor positive (ER or PR positive) metastatic breast...as aromatase inhibitors, to keep the cancer under ...
(Date:9/4/2008)...-- A groundbreaking program,dealing with the deter...men, their shorter life spans, unmet gender specif... Wednesday, September 17 at White Plains,Hospital....Westchester,medical and psychiatric societies will...nel Tiger, Ph.D., Dr. Legatto, an internationally...
(Date:9/4/2008)... say could help doctors evaluate risks , ...afety experts say that almost all kids who are all...ose monitoring and a set of standard precautions. ...ics , a team of experts led by the Johns Hopkins C...nstructions -- an algorithm -- to help physicians ...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2...t smaller amount of teenagers are drinking on a re...coming harder for youngsters to get hold of alcoh...2% in 2005 to 17% in the latest research. Those wh...k - cut down from 50% to 44%. On the other hand a ...
... reports have confirmed that she was drunk and had...ash in Beverly Hills on Memorial Day weekend. Ac...eports say that the Mean Girls star had cocaine an...alcohol in her system when she was arrested last m...
...nderstand the mechanism by which cells grow and ca...athogen Listeria Monocytogenes in their project. ...ntral Florida Microbiology Professor Keith Ireton,...protein called InlB induces internalisation and de...
...der in Andhra Pradesh, Thursday announced that it ...r to set up new state-of-the-art hospitals in six ...leted 10 years, plans to open new hospitals in Mad...a, Chhattisgarh, Gujarat, Orissa and Kerala. The ...
Other Medicine News:Health News:New Study That Small Amount of Teenagers Drinks on a Regular Basis 2Health News:Study of Bacterial Pathogen may Give Insight to Cancer Development 2(Date:9/6/2008)...acy of First-in-Class Neurally Acting Anti-Migr...aine, LONDON, Sept. 6 /- CoLucid Pha...mpany focusing on therapies for central nervous,sy...lead compound COL-144,in the treatment of acute mi... and effective in relieving migraine headaches. CO...
(Date:9/5/2008)...FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ) an...hritis data,at the Marcus Evans conference on Immu.... Daniel Zimmerman, Senior Vice President of Resea... CEL-SCI,s rheumatoid,arthritis vaccine CEL-2000 p...sed by rheumatoid arthritis in an animal model of ...
(Date:9/4/2008)...Newswire/ -- Cytopia Limited (ASX:,CYT) today anno...e Ib/II,study of CYT997, the company,s novel vascu...an aggressive form of brain cancer known as gliobl...is the first Phase II efficacy study in highly,vas... the second in its,suite of Phase II studies desig...
(Date:9/4/2008)..., and Presented at ESC Congress-, PHILADELPHIA, S...ional,study, the GISSI Heart Failure (GISSI-HF) st...esters reduced all cause mortality and hospital,ad...th chronic heart,failure. These findings are publi... and were presented at the European Cardiovascular...
Breaking Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Internal Medicine 2008 media advisory 17936 1Internal Medicine 2008 media advisory 17936 2Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 1Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 2Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 3Scientists aim to boost world energy supplies with microbes 21 3101 1Scientists aim to boost world energy supplies with microbes 21 3101 2Scientists aim to boost world energy supplies with microbes 21 3101 3Scientists aim to boost world energy supplies with microbes 21 3101 4Scientists determine drug target for the most potent botulinum neurotoxin 3099 1Scientists determine drug target for the most potent botulinum neurotoxin 3099 2... Evaluable Patients Receiving Combination of,Bavit...,Tumor Response or Stable Disease - , - 75% of ... Gemcitabine , ,Achieved Objective Tumor...Patients Receiving Combination of Bavituximab Plus...ive Tumor Response - , - Trial Results Suppo...
... (Asasantin® Retard) considered by many as,fir...IM, Germany, 31 May 2007 - New data presented toda...w confirm that therapy,with dipyridamole plus ASA ...d as Aggrenox® or Asasantin® Retard) is su...ents in patients who had,a TIA or minor ischaemic ...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 2Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 3Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 4Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 5New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: